Cardiovascular risk factors and venous thromboembolism - A meta-analysis

被引:771
作者
Ageno, Walter [1 ]
Becattini, Cecilia [2 ]
Brighton, Timothy [3 ]
Selby, Rita [4 ]
Kamphuisen, Pieter W. [5 ]
机构
[1] Univ Insubria, Dept Clin Med, Varese, Italy
[2] Univ Perugia, Dept Internal Med, I-06100 Perugia, Italy
[3] Prince Wales Hosp, SEALS, Sydney, NSW, Australia
[4] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[5] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
关键词
atherosclerosis; risk factors; thrombosis; veins;
D O I
10.1161/CIRCULATIONAHA.107.709204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The concept that venous thromboembolism (VTE) and atherosclerosis are 2 completely distinct entities has recently been challenged because patients with VTE have more asymptomatic atherosclerosis and more cardiovascular events than control subjects. We performed a meta-analysis to assess the association between cardiovascular risk factors and VTE. Methods and Results-Medline and EMBASE databases were searched to identify studies that evaluated the prevalence of major cardiovascular risk factors in VTE patients and control subjects. Studies were selected using a priori defined criteria, and each study was reviewed by 2 authors who abstracted data on study characteristics, study quality, and outcomes. Odds ratios or weighted means and 95% confidence intervals (CIs) were then calculated and pooled using a random-effects model. Statistical heterogeneity was evaluated through the use of chi(2) and Iota(2) statistics. Twenty-one case-control and cohort studies with a total of 63 552 patients met the inclusion criteria. Compared with control subjects, the risk of VTE was 2.33 for obesity (95% CI, 1.68 to 3.24), 1.51 for hypertension (95% CI, 1.23 to 1.85), 1.42 for diabetes mellitus (95% CI, 1.12 to 1.77), 1.18 for smoking (95% CI, 0.95 to 1.46), and 1.16 for hypercholesterolemia (95% CI, 0.67 to 2.02). Weighted mean high-density lipoprotein cholesterol levels were significantly lower in VTE patients, whereas no difference was observed for total and low-density lipoprotein cholesterol levels. Significant heterogeneity among studies was present in all subgroups except for the diabetes mellitus subgroup. Higher-quality studies were more homogeneous, and significant associations remained unchanged. Conclusions-Cardiovascular risk factors are associated with VTE. This association is clinically relevant with respect to individual screening, risk factor modification, and primary and secondary prevention of VTE. Prospective studies should further investigate the underlying mechanisms of this relationship.
引用
收藏
页码:93 / 102
页数:10
相关论文
共 65 条
  • [51] PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects
    Seguí, R
    Estellés, A
    Mira, Y
    España, F
    Villa, P
    Falcó, C
    Vayá, A
    Grancha, S
    Ferrando, F
    Aznar, J
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (01) : 122 - 128
  • [52] Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives
    Sidney, S
    Petitti, DB
    Soff, GA
    Cundiff, DL
    Tolan, KK
    Quesenberry, CP
    [J]. CONTRACEPTION, 2004, 70 (01) : 3 - 10
  • [53] BETA-THROMBOGLOBULIN LEVELS IN RELATION TO MYOCARDIAL-INFARCTION - PRELIMINARY-OBSERVATIONS
    SIMMONDS, JP
    OMALLEY, BP
    MASKILL, MR
    OCONNOR, JF
    BURRIDGE, DJ
    [J]. ACTA HAEMATOLOGICA, 1980, 64 (03) : 172 - 175
  • [54] Why should statins prevent venous thromboembolism? A systematic literature search and a call for action
    Squizzato, A.
    Romualdi, E.
    Ageno, W.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (09) : 1925 - 1927
  • [55] FIBRINOLYTIC VARIABLES ARE RELATED TO AGE, SEX, BLOOD-PRESSURE, AND BODY BUILD MEASUREMENTS - A CROSS-SECTIONAL STUDY IN NORSJO, SWEDEN
    SUNDELL, IB
    NILSSON, TK
    RANBY, M
    HALLMANS, G
    HELLSTEN, G
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1989, 42 (08) : 719 - 723
  • [56] Cardiovascular risk factors and venous thromboembolism incidence - The longitudinal investigation of thromboembolism etiology
    Tsai, AW
    Cushman, M
    Rosamond, WD
    Heckbert, SR
    Polak, JF
    Folsom, AR
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (10) : 1182 - 1189
  • [57] Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study
    van der Hagen, P. . B. .
    Folsom, A. R.
    Jenny, N. S.
    Heckbert, S. R.
    O'Meara, E. S.
    Reich, L. . M.
    Rosendaal, F. R.
    Cushman, M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (09) : 1903 - 1908
  • [58] Vayá A, 2002, CLIN HEMORHEOL MICRO, V26, P41
  • [59] Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors
    Vayá, A
    Mira, Y
    Ferrando, F
    Contreras, MT
    Estelles, A
    España, F
    Corella, D
    Aznar, J
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (01) : 255 - 259
  • [60] Platelet dysfunction in type 2 diabetes
    Vinik, AI
    Erbas, T
    Park, TS
    Nolan, R
    Pittenger, GL
    [J]. DIABETES CARE, 2001, 24 (08) : 1476 - 1485